Potassium-magnesium citrate versus potassium chloride in thiazide- induced hypokalemia

Kidney International

Volumn 57, Issue 2, 2000, Pages 607-612

  Wuermser, Lisa Ann ^a   Reilly, Christopher ^a   Poindexter, John R ^a   Sakhaee, Khashayar ^a   Pak, Charles Y C ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Diuretic therapy; Hypercalciuric nephrolithiasis; Hypokalemia; Hypomagnesemia

Indexed keywords

CITRATE POTASSIUM; HYDROCHLOROTHIAZIDE; MAGNESIUM CITRATE; POTASSIUM; POTASSIUM CHLORIDE; THIAZIDE DIURETIC AGENT;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED DISEASE; HUMAN; HYPOKALEMIA; KIDNEY TUBULE ABSORPTION; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; URINARY EXCRETION; URINE PH;

EID: 0033943535     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00881.x     Document Type: Article

References (18)

1. 1. YENDT ER, GUAY GF, GARCIA DA: Use of thiazide in the prevention of renal calculi. Can Med Assoc J 102:614-620, 1970
2. 2. MORGAN DB, DAVIDSON C: Hypokalemia and diuretics: An analysis of publications. Br Med J 280:905-908, 1980
3. 3. DYCKER T, WESTER PO: Intracellular magnesium loss after diuretic administration. Drugs 28:161-166, 1984
4. 4. NICAR MJ, PETERSON R, PAK CYC: Use of potassium citrate as potassium supplement during thiazide therapy of calcium nephrolithiasis. J Urol 131:430-433, 1984
5. 5. ISERI LT: Role of magnesium in cardiac tachyarrhythmia. Am J Cardiol 65:45K-50K, 1990
6. 6. WHANG R, FLINK EB, DYCKER T, WESIER PO, AIKAWA JK, RYAN MP: Magnesium depletion as a cause of refractory potassium depletion. Arch Intern Med 145:1686-1689, 1985
7. 7. PAK CYC, PETERSON R, SAKHAEE K, FULLER C, PREMINGER G, REISCH J: Correction of hypocitraturia and prevention of stone formation by combined thiazide and potassium citrate therapy in thiazide-unresponsive hypercalciuric nephrolithiasis. Am J Med 79:284-288, 1985
8. 8. SAKHAEE K, ALPERN R, JACOBSON HR, PAK CYC: Contrasting effects of various potassium salts on renal citrate excretion. J Clin Endocrinol Metab 72:396-400, 1991
9. 9. PAK CYC, KOENIG K, KHAN R, HAYNES S, PADALINO P: Physicochemical action of potassium-magnesium citrate in nephrolithiasis. J Bone Miner Res 7:283-287, 1992
10. 10. ETTINGER B, PAK CYC, CITRON JT, VANGESSEL A: Potassium magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol 158:2069-2073, 1997
11. 11. RUML LA, WUERMSER LA, POINDEXTER J, PAK CYC: The effect of varying molar ratios of potassium-magnesium citrate on thiazideinduced hypokalemia and magnesium loss. J Clin Pharmacol 38:1035-1041, 1998
12. 12. RUML LA, GONZALEZ G, TAYLOR RN, WUERMSER LA, PAK CYC: Effect of varying doses of potassium-magnesium citrate on thiazide-induced hypokalemia and magnesium loss. Am J Ther 6:45-50, 1999
13. 13. RUML LA, PAK CYC: The effect of potassium-magnesium citrate on thiazide-induced hypokalemia and magnesium loss: Comparison with potassium citrate and magnesium citrate. Am J Kidney Dis 34:107-113, 1999
14. 14. KASSIRER JP, BERKMAN PM, LAWRENZ DR, SCHWARTZ WB: The critical role of chloride in the correction of hypokalemic alkalosis in man. Am J Med 38:172-189, 1965
15. 15. CARLISLE EJF, DONNELLY SM, ETHIER JH, QUAGGIN SE, KAISER UB, VASUVATTAKUL S, KAMEL KS, HALPERIN ML: Modulation of the secretion of potassium by accompanying anions in humans. Kidney Int 39:1206-1212, 1991
16. 16. PAK CYC, FULLER C, SAKHAEE K, PREMINGER GM, BRITTON F: Long-term treatment of calcium nephrolithiasis with potassium citrate. J Urol 134:11-19, 1985
17. 17. SEBASTIAN A, HARRIS ST, OTTAWAY JH, TODD KM, MORRIS RC: Effect of potassium bicarbonate on mineral balance and skeletal metabolism in postmenopausal women. N Engl J Med 330:1776-1781, 1994
18. 3: Pathophysiological and clinical implications. Semin Nephrol 5:487-493, 1999